SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:gup.ub.gu.se/292812"
 

Search: onr:"swepub:oai:gup.ub.gu.se/292812" > Ketanserin in hyper...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Ketanserin in hypertension. Early clinical evaluation and dose finding study of a new 5-HT2 receptor antagonist.

Andrén, Lennart, 1946 (author)
Gothenburg University,Göteborgs universitet,Medicinska institutionen,Department medicine
SVensson, Anders (author)
Gothenburg University,Göteborgs universitet,Medicinska institutionen,Department medicine
Dahlöf, Björn, 1953 (author)
Gothenburg University,Göteborgs universitet,Medicinska institutionen,Department medicine
show more...
Eggertsen, Robert, 1948 (author)
Gothenburg University,Göteborgs universitet,Medicinska institutionen,Department medicine
Hansson, Lennart (author)
Gothenburg University,Göteborgs universitet,Medicinska institutionen,Department medicine
show less...
 (creator_code:org_t)
1983
1983
English.
In: Acta medica Scandinavica. - 0001-6101. ; 214:2, s. 125-30
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Ketanserin, a new 5-hydroxy-tryptamine antagonist, was given at three different dosage levels (double-blind, randomized) in a dose finding study for 2 months to 31 patients with mild to moderately severe essential hypertension. Treatment with ketanserin was then continued until 9 months had been completed. A significant antihypertensive effect was demonstrated at daily dosages of 20 mg t.i.d. or 40 mg t.i.d. The antihypertensive effect was similar to that of previous multiple drug treatment with conventional drugs. However, 60 mg t.i.d. was not acceptable, at least not as initial dosage. At this dose level, 8 out of 10 patients had to be withdrawn from the study during the initial phase due to unwanted effects. It is conceivable that alpha 1-adrenoceptor blockade may have played a role at this dose level, since postural reactions were observed which was otherwise not the case during this study. Ketanserin is a new and interesting alternative in the treatment of hypertension. At the same time it offers a tool by which the role of 5-hydroxy-tryptamine in the regulation of arterial pressure can be investigated.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Allmänmedicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- General Practice (hsv//eng)

Keyword

Adult
Aged
Antihypertensive Agents
therapeutic use
Blood Pressure
drug effects
Clinical Trials as Topic
Double-Blind Method
Female
Heart Rate
drug effects
Humans
Hypertension
drug therapy
Ketanserin
Male
Middle Aged
Piperidines
administration & dosage
therapeutic use
Random Allocation
Serotonin Antagonists
therapeutic use

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view